- Report
- January 2022
- 60 Pages
Global
From €3819EUR$3,950USD£3,259GBP
- Report
- November 2021
- 101 Pages
Global
From €4351EUR$4,500USD£3,712GBP
- Drug Pipelines
- April 2021
- 64 Pages
Global
€21272EUR$22,000USD£18,149GBP
- Report
- December 2022
- 162 Pages
Global
From €2417EUR$2,500USD£2,062GBP
- Report
- August 2022
United States
From €1876EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €1054EUR$1,090USD£899GBP
- Report
- August 2021
Global
From €3858EUR$3,990USD£3,292GBP
- Report
- August 2021
Europe
From €3307EUR$3,420USD£2,821GBP
- Report
- February 2021
Global
From €2862EUR$2,960USD£2,442GBP
- Report
- January 2023
- 90 Pages
Global
From €3379EUR$3,495USD£2,883GBP
- Clinical Trials
- August 2020
- 1620 Pages
Global
From €2417EUR$2,500USD£2,062GBP
- Report
- March 2020
- 154 Pages
Global
From €10631EUR$10,995USD£9,071GBP
- Report
- December 2019
- 38 Pages
Global
From €3863EUR$3,995USD£3,296GBP
- Drug Pipelines
- October 2020
- 576 Pages
Global
From €1934EUR$2,000USD£1,650GBP
- Drug Pipelines
- December 2019
- 27 Pages
Global
From €3384EUR$3,500USD£2,887GBP
- Report
- April 2019
- 71 Pages
Global
From €6763EUR$6,995USD£5,771GBP
- Report
- May 2023
- 79 Pages
Global
From €3500EUR$3,878USD£3,091GBP
- Report
- May 2023
- 109 Pages
Global
From €3500EUR$3,878USD£3,091GBP
- Report
- August 2021
- 73 Pages
Global
From €3200EUR$3,545USD£2,826GBP
- Report
- August 2022
- 541 Pages
Global
From €2417EUR$2,500USD£2,062GBP
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more